Published in Gut on August 01, 1993
The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut (2001) 10.07
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology (2007) 3.39
Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol (2014) 2.27
Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut (1998) 2.14
Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut (2002) 2.13
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79
Cancer surveillance in ulcerative colitis--a time for reappraisal. Gut (1994) 1.56
Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut (2003) 1.32
Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer (2003) 1.25
Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. J Gastrointest Surg (2008) 1.12
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis (2009) 1.10
p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease. Dig Dis Sci (2007) 0.93
A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut (2000) 0.90
5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol (2005) 0.90
Economic comparison of current endoscopic practices: Barrett's surveillance vs. ulcerative colitis surveillance vs. biopsy for sprue vs. biopsy for microscopic colitis. Dig Dis Sci (2005) 0.88
Screening and surveillance for asymptomatic colorectal cancer in IBD. Gut (2003) 0.88
Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World J Gastroenterol (2014) 0.86
Techniques for targeting screening in ulcerative colitis. Postgrad Med J (2007) 0.86
Surveillance programmes for neoplasia in colitis. J Gastroenterol (2010) 0.81
Dysplasia in ulcerative colitis--clinical consequences? Langenbecks Arch Surg (2004) 0.81
Magnifying chromoscopy, a novel and useful technique for colonoscopy in ulcerative colitis. World J Gastroenterol (2007) 0.81
Expression of costimulatory molecule CD80 in colonic dysplasia in ulcerative colitis: an immunosurveillance mechanism against colorectal cancer? Int J Colorectal Dis (2006) 0.81
Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC. Oncotarget (2016) 0.80
Diagnostic value of DNA image cytometry in ulcerative colitis. Dig Dis Sci (2001) 0.78
CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis. Oncotarget (2015) 0.78
Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients with Ulcerative Colitis with Low-Grade Dysplasia: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol (2016) 0.75
Colonoscopic surveillance in ulcerative colitis. Gut (1994) 0.75
Utility of surveillance colonoscopy in ulcerative colitis. Gut (1994) 0.75
Pros and cons of medical management of ulcerative colitis. Clin Colon Rectal Surg (2010) 0.75
Combining aneuploidy and dysplasia for colitis' cancer risk assessment outperforms current surveillance efficiency: a meta-analysis. Int J Colorectal Dis (2016) 0.75
Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection. Dig Dis Sci (2016) 0.75
Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut (1967) 7.39
Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J (1966) 4.27
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
THE CANCER RISK IN ULCERATIVE COLITIS. Lancet (1964) 3.60
Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med (1971) 3.10
Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology (1981) 2.75
Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet (1983) 2.67
Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med (1987) 2.61
Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology (1977) 2.61
Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology (1992) 2.51
Cancer risk in extensive ulcerative colitis. Ann Surg (1978) 2.40
Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut (1990) 1.99
Cancer surveillance in ulcerative colitis. Gastroenterology (1991) 1.93
Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Gut (1986) 1.87
Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology (1991) 1.86
Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology (1988) 1.81
Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology (1985) 1.66
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Surveillance in ulcerative colitis: burdens and benefit. Gut (1988) 1.40
Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology (1975) 1.36
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci (1989) 1.34
Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut (1990) 1.24
Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol (1988) 1.24
Compliance, cost, and common sense limit cancer control in colitis. Gut (1986) 1.20
Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut (1991) 1.16
Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology (1988) 1.16
The precarcinomatous phase of ulcerative colitis. Curr Top Pathol (1976) 1.15
Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol (1980) 1.11
Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol (1990) 1.11
Precancer and cancer in inflammatory bowel disease. Pathology (1985) 1.07
Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut (1987) 1.06
Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis. Lancet (1980) 1.06
The DNA content in cancer and dysplasia in chronic ulcerative colitis. Histopathology (1987) 1.01
Lectin and mucin histochemistry as an aid to cancer surveillance in ulcerative colitis. Histopathology (1987) 0.87
Screening for gastrointestinal cancer: an epidemiological review. Gut (1991) 0.79
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ (1997) 5.80
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet (2001) 5.56
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Early endoscopy of oesophagus, stomach, and duodenal bulb in patients with haematemesis and melaena. Br Med J (1973) 4.84
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15
Does cryptic gluten sensitivity play a part in neurological illness? Lancet (1996) 3.92
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group. Gastroenterology (1998) 3.90
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Pancreatography in chronic pancreatitis: international definitions. Gut (1984) 2.37
Early gastric cancer in Europe. Gut (1997) 2.34
Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection. Gut (2004) 2.33
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
Effect of cimetidine on the gastric bacterial flora. Lancet (1980) 2.18
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J (1978) 2.12
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Aliment Pharmacol Ther (2014) 2.11
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy (2005) 1.95
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology (1999) 1.88
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut (1986) 1.83
Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther (2001) 1.81
Intestinal permeability and screening tests for coeliac disease. Gut (1980) 1.81
Endoscopic mucosal resection. Endoscopy (2001) 1.76
The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis (1988) 1.72
Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology (1989) 1.71
Disinfection of gastrointestinal fibre endoscopes. Lancet (1974) 1.71
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70
Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology (1980) 1.69
Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68
The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68
Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66
Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut (1982) 1.65
Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64
Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut (1999) 1.62
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Permeability of the small intestine to substances of different molecular weight. Gut (1970) 1.61
Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg (1986) 1.60
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. Aliment Pharmacol Ther (1999) 1.59
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58
Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58
Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57
Disinfection in upper-digestive-tract endoscopy in Britain. Lancet (1981) 1.57
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut (1990) 1.56